Abstract Background: People who use cannabis medically do so more frequently than those who use nonmedically, potentially placing them at…
Abstract Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting voluntary muscle movement as well as cognitive and…
Abstract Medicinal cannabis is being used worldwide and there is increasing use of novel cannabis products in the community. Cannabis…
Abstract Background: Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been…
Abstract There is a significant global upsurge in the number and proportion of older persons in the population. With this…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s42238-023-00202-y. Article type: Research Article Keywords: Medical cannabis, THC,…
Abstract Introduction: Cannabis contains cannabidiol (CBD), the main non-psychoactive phytocannabinoid, but also many other phytocannabinoids that have therapeutic potential in…
Abstract A purified preparation of cannabidiol (CBD), a cannabis constituent, has been approved for the treatment of intractable childhood epilepsies…
Abstract Introduction: Synthetic cannabinoid receptor agonists (SCRAs) are a diverse class of new psychoactive substances that have been associated with…
Abstract Introduction: Cannabidiol (CBD) has been clinically approved for intractable epilepsies, offering hope that novel anticonvulsants in the phytocannabinoid class…